Selective Estrogen Receptor Modulators [horm, phsu]
Women [popg]
Panacea [euka]
Purpose [ftcn]
Review [inpr]
To [qlco]
Relevant [qlco]
Experimental [qlco]
Clinical information [clna]
Available [ftcn]
Selective Estrogen Receptor Modulators [horm, phsu]
Potential [qlco]
Agent [chvf]
postmenopausal [tmco]
Addition [ftcn]
Mechanisms [ftcn]
Action [ftcn]
Drugs [phsu]
Selective Estrogen Receptor Modulators [horm, phsu]
Represent [acty]
Group [idcn]
Antiestrogens [phsu]
possess [mobd]
Agonist [phsu]
Action [ftcn]
Bone [bpoc]
Lipids [lipd]
Lipoproteins [aapp, bacs]
Antagonist [ortf]
Action [ftcn]
Endometrium [bpoc]
Breast [bpoc]
Theory [idcn]
Drugs [phsu]
Bone Density [clna]
Risk [qlco]
Osteoporotic fracture [dsyn]
coronary heart disease [dsyn]
Same [qlco]
Time [tmco]
Lower [spco]
Incidences [qnco]
Breast [bpoc]
Endometrial Neoplasms [neop]
Short-term [tmco]
Data [idcn]
Raloxifene [orch, phsu]
Suggest [idcn]
Bone [bpoc]
Preserved [lbpr]
Lipid [lipd]
Profile [lbpr]
Atherogenesis [patf]
Long-term [tmco]
studies [lbpr]
Needed [qlco]
To [qlco]
Raloxifene [orch, phsu]
Selective Estrogen Receptor Modulators [horm, phsu]
Associated [qlco]
Decrease [qlco]
Risk [qlco]
Breast [bpoc]
Endometrial Cancer [neop]
